Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Meningeal Carcinomatosis 7Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Burkitt Lymphoma 5Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Meningeal Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Glioblastoma 2Brain Neoplasms 2Astrocytoma 2Vomiting 1Uveal Melanoma 1Psychomotor Agitation 1Pain, Postoperative 1Oligodendroglioma 1Nevus 1Neoplasm Recurrence, Local 1Myelodysplastic Syndromes 1Meningioma 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Transdermal Patch 1Spinal Puncture 1Spectrum Analysis, Raman 1Specimen Handling 1Nivolumab 1Mass Screening 1Magnetic Resonance Spectroscopy 1Genome 1Everolimus 1Diagnostic Imaging 1Dermoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nevus × Spinal Puncture × Clear all
NCT03025256 2026-05-05

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Recruiting
75 enrolled
DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡